Glucagon injection, solution
GVOKE is a glucagon injection used to treat severe low blood sugar (hypoglycemia) in people with diabetes. It comes in auto-injectors, pre-filled syringes, and kits for subcutaneous or intravenous use. Glucagon works by raising blood sugar levels quickly. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | GVOKE is a glucagon injection used to treat severe low blood sugar (hypoglycemia) in people with diabetes. It comes in auto-injectors, pre-filled syringes, and kits for subcutaneous or intravenous use. Glucagon works by raising blood sugar levels quickly. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Glucagon injection, solution",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Glucagon injection, solution — ANDA 212097 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212097"
}
]
|
| identifier | ANDA212097 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"fda",
"medications",
"prescription-drugs"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Glucagon injection, solution |
